2020年7月~9月にEurofins Disoveryが発表した学会ポスター(製品)を、下記リンクより閲覧およびダウンロードしていただけます。発表ポスターに関してのご質問がございましたらお問い合わせフォームよりお気軽にご連絡ください。
例年とは異なり全ての学会がウェブ開催となりました。会期中に弊社ブースにご訪問いただきましたお客様、誠にありがとうございます。
。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚。*゚*
★Eurofins Discoveryでは、創薬に役立つ技術・サービスに関するニュースレターを配信しています。配信をご希望の方は下記フォームよりお知らせください。
ご意見・ご質問は、お問い合わせフォームからお気軽にどうぞ。
。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚*。,。*゚。*゚*
![[Immuno-Oncology Summit 2020] Driving Robust and Reproducible ADCC and T Cell Redirection with Single Donor KILR® CD16 Effector Cells](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21196.png&hash=a175805473eda315ad2e8e6da092092abb3b8a12a6d87de89129313cde653860&ext=.png)
![[Immuno-Oncology Summit 2020] Building Robust and Simple Cell-Based Assays for Interleukins and Their Receptors](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21195.png&hash=c952315d666e2fda28a066a1e3a118db28099bdcd25521a7ff79715bda664a21&ext=.png)
![[Immuno-Oncology Summit 2020] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21197.png&hash=0b31fc2c6df03ee32394bad9d248c0b83fc72d9031ba27c6212cd53a003a75cb&ext=.png)
![[DOT 2020] Detection of Endogenous Protein Turnover Induced by Targeted Degraders](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21180.png&hash=8ff5f75264fc55fedc89cf4bee723d54124724a8369f23693a8686e7f801c4df&ext=.png)
![[DOT 2020] New PathHunter Reporter Assays: Analysis of PD-1 Checkpoint Receptor and NFAT Signaling Pathways](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21148.png&hash=2618a0d03daacad20392de1a034d5c15f2d99b51eb371d01509a46a2ff59685d&ext=.png)
![[DOT 2020] Identify Effective Therapeutics with Simple, Quantitative Cell-Based Assays That Measure Receptor Internalization](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21186.png&hash=20032724e7fd0d939bc4c3e64539c696684a07a4bdd25e758ac5e05ccfd2ea85&ext=.png)
![[Advances in Immuno-Oncology Congress] Driving Robust and Reproducible ADCC and T Cell Redirection with Single Donor KILR® CD16 Effector Cells](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21147.png&hash=cb0568990c6bc7f8f67fce46cb5edfab9208d4f8f22b93573c22ba9551124f4c&ext=.png)
![[Advances in Immuno-Oncology Congress] Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\tn21126_1.png&hash=b07fafa2bbcd0e277f7d335c5454d524aae00af85b4c05debaf331f52f226667&ext=.png)
![[Advances in Immuno-Oncology Congress] Evaluation of Small Molecules for Immuno-Oncology Development Using BioMAP Early Screening Phenotypic Services](https://www.discoverx.com/CMSPages/GetAmazonFile.aspx?path=~\discoverx\media\discoverxcontentfiles\pageimages\posters%202020\21177_tn.png&hash=f970f2ab0f7238428b22181148916e4b445ceec13856149e4484efb20bb82cfb&ext=.png)
0 件のコメント:
コメントを投稿